Vanderbilt Ingram Cancer Center Archives
‘Biopsy Queen’ reaches milestone number of procedures
Feb. 9, 2023—Vanderbilt-Ingram Cancer Center's Krista Kuhnert-Gainer, ACNP has performed more than 20,000 bone marrow biopsies since 1996.
Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs
Feb. 9, 2023—Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.
Vanderbilt-Ingram joins CancerLinQ quality initiative
Feb. 9, 2023—Vanderbilt-Ingram Cancer Center is now participating in CancerLinQ, a technology initiative focused on improving patient care that tracks quality metrics in real time.
Berlin named director of Division of Hematology and Oncology
Feb. 6, 2023—Jordan Berlin, MD, has been named director of Vanderbilt’s Division of Hematology and Oncology.
Surgeons target pancreatic cancer with electrons using new technology
Jan. 19, 2023—Vanderbilt surgeons recently treated a pancreatic cancer patient using IntraOp Mobetron IORT with electrons — the first surgery performed in Tennessee with this new technology utilizing intraoperative radiotherapy in the operating room.
Novel lung cancer biomarker
Jan. 9, 2023—Autoantibodies against the p53 tumor suppressor protein may be a novel biomarker for identifying people, especially African Americans, at high risk for lung cancer.
New approach outperforms existing cancer susceptibility models
Jan. 5, 2023—A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.
Lovly receives Asclepios Award from GO2 for Lung Cancer
Dec. 8, 2022—Vanderbilt's Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers.
Winkfield named to American Cancer Society Cancer Action Network’s national board of directors
Dec. 5, 2022—KarenWinkfield, MD, PhD, executive director of the Meharry-Vanderbilt Alliance, has been named one of three new members of the American Cancer Society Cancer Action Network’s national board of directors.
Vanderbilt mourns loss of surgical leader Beauchamp
Nov. 30, 2022—R. Daniel Beauchamp, MD, former chair of the Section of Surgical Sciences at Vanderbilt University Medical Center and surgeon-in-chief of Vanderbilt University Hospital, died Nov. 27 at Alive Hospice. He was 66 years old.
Surgery for hereditary breast cancer
Nov. 17, 2022—Similar rates of bilateral mastectomy in women with inherited mutations in high- and moderate-penetrance genes raises concerns about possible overtreatment of some patients, Vanderbilt researchers report.
Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis
Nov. 16, 2022—Researchers from from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation myocarditis.
